(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THE KINDER FARMACEUTICAL COMPANY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

THE KINDER FARMACEUTICAL COMPANY

ST13

US500000090980058

Class

5

Filing

90980058

Registration

7151804

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

08/29/2023

Trademark type

Word

Nice classes

5

Filing date

03/26/2021

Registration date

08/29/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/29/2023

Last transaction

08/29/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/30/2022

First use in commerce

09/30/2022

Drawing code

4

Owner type

16

Owner location

REDONDO BEACH, CA

Examiner

BRYANT, ALEXANDRIA

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

KINDERFARMS LLC
KINDERFARMS LLC

Representatives

H. David Starr MUNCY, GEISSLER, OLDS & LOWE, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

dietary supplementsnutritional supplementsmineral supplements; beveragesprotein supplement shakesdietary supplemental drinks in the nature of vitamin and mineral beveragesvegan protein for use as a nutritional supplement in ready-to-drink beveragesdietary supplement beverage for promoting digestion; electrolyte drinks for medical purposes; electrolyte replacement solutions; liquid nutritional supplement; liquid protein supplements; liquid vitamin supplements; nutritional supplement shakes; nutritional supplements in the form of powder; protein supplements; cough treatment preparations; preparations for treating colds; cough syrups; over the counter (OTC) drugspreparations and medicinespreparations promoting digestive health

Publications

History of USPTO decisions and trademark events.

36 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/29/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

08/29/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/22/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/21/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/28/2023

DPCC

DIVISIONAL PROCESSING COMPLETE

06/28/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/20/2023

IUAF

USE AMENDMENT FILED

05/23/2023

DRRR

DIVISIONAL REQUEST RECEIVED

05/23/2023

EISU

TEAS STATEMENT OF USE RECEIVED

05/23/2023

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

05/23/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/16/2023

EX1G

SOU EXTENSION 1 GRANTED

05/13/2023

EXT1

SOU EXTENSION 1 FILED

05/13/2023

EEXT

SOU TEAS EXTENSION RECEIVED

05/13/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

04/12/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/15/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/20/2022

PUBO

PUBLISHED FOR OPPOSITION

09/20/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/31/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/12/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/27/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/26/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

07/26/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/24/2022

GNSL

LETTER OF SUSPENSION E-MAILED

02/24/2022

CNSL

SUSPENSION LETTER WRITTEN

02/24/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/06/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/05/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/05/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/05/2021

GNRT

NON-FINAL ACTION E-MAILED

11/05/2021

CNRT

NON-FINAL ACTION WRITTEN

11/05/2021

DOCK

ASSIGNED TO EXAMINER

10/28/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/02/2021

NWAP

NEW APPLICATION ENTERED

03/30/2021

Continuous trademark protection

Get notified about every new filing that threatens THE KINDER FARMACEUTICAL COMPANY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.